Oramorph (Morphine Sulfate)

Morphine Sulfate, the active ingredient in Oramorph, is an opioid analgesic presented as a strength/form for oral use. It is employed to manage moderate to severe pain in adult patients when other analgesics are insufficient. GNH USA supplies Oramorph as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Oramorph as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Oramorph is an opioid analgesic that acts on the central nervous system to relieve pain.

- Acute postoperative pain: provides effective analgesia following surgical procedures. - Cancer‑related pain: helps control persistent pain associated with malignant disease. - Severe chronic pain: used when other analgesics fail to provide adequate relief.

Side effects vary with dosage and individual patient factors.

Common Side Effects: - Nausea and vomiting - Constipation - Drowsiness or sedation - Dry mouth - Sweating - Itching (pruritus)

Serious or Rare Side Effects: - Respiratory depression - Severe hypotension - Bradycardia - Hallucinations or delirium - Dependence or withdrawal syndrome - Anaphylactic reactions

When using Oramorph, several safety considerations are essential.

- Assess pain level: ensure opioid therapy is appropriate for the severity of pain. - Monitor respiratory function: watch for signs of respiratory depression, especially after dose initiation. - Evaluate renal and hepatic function: dose adjustments may be required in impairment. - Avoid concurrent CNS depressants: limit use with alcohol, benzodiazepines, or other sedatives. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Oramorph can interact with a range of medications, influencing its safety and efficacy.

Major Interactions (Avoid): - Concurrent use with strong CYP3A4 inhibitors (e.g., ketoconazole) may increase morphine levels and risk of toxicity. - Co‑administration ​         ​   ​  ​  ​  ​  ​  ​  ​  ​   ​  ​  ​  ​  ​  ​  ​ ​  ​  ​  ​  ​  ​  ​  ​  ​ ​  ​  ​     ​  ​ ​  …   -    ... ...   -  ...  -  …